2024-510767-30-00招募中2 期
SGM-CBM: A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of colorectal brain metastases.
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 10
- 试验地点
- 2
- 主要终点
- Based upon the primary objective: “To assess the performance of SGM-101 in the intraoperative detection of brain metastases of colorectal origin” we propose the following primary endpoint: Concordance rate between the pathology results with respect to the presence of cancer and the imaging assessment. This endpoint is chosen as this study serves as a proof of principle.
研究概览
简要总结
To assess the performance of SGM-101 in the intraoperative detection of brain metastases of colorectal origin.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- •Signed informed consent prior to any study-mandated procedure.
- •Patients aged over 18 years old.
- •All women of child bearing potential and all males must practice effective contraception during the study and be willing and able to continue contraception for at least 30 days after their last dose of study treatment.
- •Has the ability to communicate well with the Investigator in the Dutch language and willing to comply with the study restrictions.
- •Diagnosed with brain metastasis of colorectal origin and scheduled for a resection.
排除标准
- •History of any anaphylactic reaction;
- •Previous use of SGM-
- •Previous use of SGM-
- •Other malignancies either currently active or diagnosed in the last 5 years, except adequately treated in situ carcinoma of the cervix and basal or squamous cell skin carcinoma.
- •Patients pregnant or breastfeeding (pregnancy should be ruled out by a pregnancy test within two weeks prior to administration of the conjugate).
- •Any condition that the investigator considers to be potentially jeopardizing the patient’s well-being or the study objectives (following a detailed medical history, physical examination, vital signs (systolic and diastolic blood pressure, pulse rate, body temperature) and 12-lead electrocardiogram (ECG)). Minor deviations from the normal range may be accepted, if judged by the Investigator to have no clinical relevance.
结局指标
主要结局
Based upon the primary objective: “To assess the performance of SGM-101 in the intraoperative detection of brain metastases of colorectal origin” we propose the following primary endpoint: Concordance rate between the pathology results with respect to the presence of cancer and the imaging assessment. This endpoint is chosen as this study serves as a proof of principle.
Based upon the primary objective: “To assess the performance of SGM-101 in the intraoperative detection of brain metastases of colorectal origin” we propose the following primary endpoint: Concordance rate between the pathology results with respect to the presence of cancer and the imaging assessment. This endpoint is chosen as this study serves as a proof of principle.
次要结局
- Concordance between intraoperative fluorescence assessment of resected lesions and their histopathology in terms of both CEA expression and tumor status.
- Modification of operative plan due to imaging (e.g. extension, reduction of resection margins, or additional resection) and change in postoperative treatment will be recorded.
- Tumor to background ratio (TBR) for fluorescence in malignant and benign tissue.
- - Treatment-emergent (serious) adverse events ((S)AEs). - Concomitant medication - Vital signs o Pulse Rate (bpm) o Systolic blood pressure (mmHg) o Diastolic blood pressure (mmHg) o Body temperature o Glasgow Coma Scale o Monitoring of unpredicted seizures o Monitoring of unpredicted focal deficits
研究者
Clinical Research Center, Department of Surgery
Scientific
Academisch Ziekenhuis Leiden
研究点 (2)
Loading locations...
相似试验
尚未招募
2 期
A FEASIBILITY STUDY OF SGM-101, A FLUOROCHROME-LABELED ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY FOR THE INTRAOPERATIVE DETECTION OF COLORECTAL BRAIN METASTASESColorectal brain metastases100274761002921110009720NL-OMON56091eids Universitair Medisch Centrum10
招募中
2 期
A performance study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for fluorescence-guided imaging to determine local extent and resectability during surgical resection of pancreatic ductal adenocarcinoma after neoadjuvant treatmentpancreatic cancerNL-OMON56065eids Universitair Medisch Centrum40
招募中
2 期
SGM-101 in Colorectal Brain Metastases.Rectal NeoplasmsRectum CancerBrain MetastasesBrain NeoplasmsBrain DiseasesBrain CancerIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal CancerGastrointestinal DiseaseIntestinal DiseaseColorectal NeoplasmsBrain TumorNCT04755920Leiden University Medical Center10
尚未招募
不适用
18FGE-180-Positron Emission Tomography in Graft Versus Host DiseaseACTRN12617000933358Royal Brisbane and Women's Hospital10
已完成
不适用
A pilot study to determine the feasibility of a glaucoma direct referral scheme for community optometrists and to evaluate the clinical quality of optometry follow up of glaucoma patients in the community and hospitalISRCTN36532888Department of Health1,000